8:20am ET
Health and Healthcare
4 Red-Hot Biotechs Highlight Jefferies Top Stocks to Buy
A series of new Jefferies reports focus on four biotech stocks that have big upside potential, regardless of the political chatter.
Companies
/Healthcare
Vertex Pharmaceuticals Inc
$541.69
▼ $5.86 (−1.07%) today
Markets closed · 5:55pm ET
VRTX Coverage
Page 9
9:05am ET
Investing
Top Analyst Upgrades and Downgrades: AK Steel, Celgene, Darden, Delphi Automotive, Johnson & Johnson, US Steel and More
The top analyst upgrades, downgrades and initiations seen on Tuesday morning include AK Steel, Celgene, Darden Restaurants, Delphi Automotive, Johnson & Johnson and U.S. Steel.
9:05am ET
Investing
Top Analyst Upgrades and Downgrades: Ariad Pharma, Comcast, ConEd, Electronic Arts, Kinder Morgan, 3M, Time Warner and More
The top analyst upgrades, downgrades and initiations seen on Monday morning include Ariad Pharmaceuticals, Comcast, ConEd, Electronic Arts, Kinder Morgan, 3M and Time Warner.
9:50am ET
Health and Healthcare
Big Pharma and Top Biotechs Highlight Jefferies Stocks to Buy Now
In a new research report from Jefferies, many of the outstanding companies in pharmaceuticals and biotech space show up among the stocks to buy.
8:20am ET
Health and Healthcare
Key FDA Decisions and Trial Results Coming in the Next 2 Months
24/7 Wall St. has collected several big FDA decisions and mid- to late-stage trials that should be coming up in late-September and October.
7:40am ET
Health and Healthcare
8 Major FDA Decisions and Trial Results to Watch for in September
24/7 Wall St. has collected several big FDA decisions and mid-to-late-stage trials that should be coming up in September.
10:10am ET
Health and Healthcare
Biotechs With Drug Pipelines Closest to Zero Valuation
Credit Suisse has taken a look at which biotech companies in its coverage have the least credit given to pipeline potential at current levels.
12:01pm ET
Health and Healthcare
5 Top Biotechs Where Future Multi-Billion Dollar Drug Pipelines are Valued Almost at Zero
Sometimes market volatility and outside shocks create a rift between market prices and real value. That may currently be the case in the largest stocks in the biotech sector within health care if RBC…
9:40am ET
Health and Healthcare
5 Major Clinical Trial Results Coming Up
24/7 Wall St. has collected several big FDA decisions and imminent clinical trial results that should be coming up in the June quarter. We have added some color.
10:15am ET
Health and Healthcare
How Analysts View Vertex After Earnings
One portfolio manager on CNBC noted that Vertex could end up being an acquisition target ahead, without mentioning any specifics.
Chris Lange 8:55am ET
Investing
Top Analyst Upgrades and Downgrades: Facebook, First Solar, Hess, Texas Instruments, US Steel, Vertex, Infinera and More
The top analyst upgrades, downgrades and initiations seen on Thursday morning include Facebook, First Solar, Hess, Texas Instruments, U.S. Steel, Vertex Pharmaceuticals and Infinera.
8:25am ET
Health and Healthcare
Top Biotech Picks Highlight Jefferies Growth Stocks to Buy
A new Jefferies research report highlights their top growth picks for this week, and the list is dominated by top biotech stocks.
10:10am ET
Investing
3 Hot Growth Stocks With Upside Potential That May Not Be Appreciated by Wall Street
Sometimes after a stock has a good run, the analysts on Wall Street start to get a little gun-shy, especially if they made a good call on the stock and it went…
10:05am ET
Health and Healthcare
5 Biotechs With the Most Upside This Earnings Cycle
Despite a modest erosion to fundamentals and sector headwinds, Jefferies does not anticipate any dramatic earnings misses, which could help sentiment continue to turn around.
9:35am ET
Health and Healthcare
8 Major Biopharma Events Coming Later in 2016 and in 2017
FDA rulings can make or break some companies. 24/7 Wall St. has collected eight key FDA decisions coming up in 2016 or 2017.